Laddar...
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
The development of non-genotoxic therapies that activate wild-type p53 in tumors is of great interest since the discovery of p53 as a tumor suppressor. Here we report the identification of over 100 small-molecules activating p53 in cells. We elucidate the mechanism of action of a chiral tetrahydroin...
Sparad:
| I publikationen: | Nat Commun |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856786/ https://ncbi.nlm.nih.gov/pubmed/29549331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-03441-3 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|